Dr Raymond Mullins graduated from the University of Sydney in 1982, and trained in clinical immunology and allergy at Royal Prince Alfred Hospital in Sydney. He completed his PhD on the immunology of mycobacterial disease (University of Sydney, 1992). Between 1992 and 1994 he was the recipient of a prestigious Neil Hamilton Fairley NHMRC Research Fellowship and worked at the Kennedy Institute of Rheumatology (London) on autoimmune thyroid disease. He is a Fellow of the Royal Australasian College of Physicians and of the Royal College of Pathologists of Australasia.

Dr Mullins practises as a consultant physician in clinical immunology and allergy in private practice in Canberra. Current clinical and research interests include the epidemiology of food allergy and anaphylaxis in Australia and the potential role of socio-economic factors and vitamin D status as possible contributing factors.

Alphagal was identified in bovine gelatine-containing products by Dr Mullins and colleagues and he delineated the clinical features of gelatine allergy in mammalian meat allergic individuals. These findings underpin our advice to mammalian meat allergic individuals regarding gelatine administration, both orally and intravenously.

He is a past President (2010-2012) of the Australasian Society for Clinical Immunology and Allergy (ASCIA) and helped develop the ASCIA-Access Economics report on The Economic Impact of Allergic Disease in Australia in 2007(www.allergy.org.au). Raymond currently chairs the ASCIA Anaphylaxis Committee and is a member of the ASCIA Education Committee and Anaphylaxis and Immunotherapy e-training working parties. He also serves on the Medical Advisory Board to Anaphylaxis Australia, the peak patient support group for allergy sufferers in Australia.

Raymond currently chairs the board of the Allergy and Immunology Foundation of Australasia (AIFA) (2013-2015) which assists in funding world leading research and education in allergy and other immune diseases in Australia and New Zealand.